Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Dementia Care Management in an Underserved Community: The Comparative Effectiveness of Two Different Approaches.

Chodosh J, Colaiaco BA, Connor KI, Cope DW, Liu H, Ganz DA, Richman MJ, Cherry DL, Blank JM, Carbone Rdel P, Wolf SM, Vickrey BG.

J Aging Health. 2015 Aug;27(5):864-93. doi: 10.1177/0898264315569454. Epub 2015 Feb 4.

PMID:
25656074
2.

Characterization of Panglial Gap Junction Networks in the Thalamus, Neocortex, and Hippocampus Reveals a Unique Population of Glial Cells.

Griemsmann S, Höft SP, Bedner P, Zhang J, von Staden E, Beinhauer A, Degen J, Dublin P, Cope DW, Richter N, Crunelli V, Jabs R, Willecke K, Theis M, Seifert G, Kettenmann H, Steinhäuser C.

Cereb Cortex. 2015 Oct;25(10):3420-33. doi: 10.1093/cercor/bhu157. Epub 2014 Jul 17.

3.

GABAB Receptors Regulate Extrasynaptic GABAA Receptors.

Connelly WM, Fyson SJ, Errington AC, McCafferty CP, Cope DW, Di Giovanni G, Crunelli V.

J Neurosci. 2013 Feb 27;33(9):3780-5. doi: 10.1523/JNEUROSCI.4989-12.2013.

4.

GABA-A Receptor Function in Typical Absence Seizures.

Crunelli V, Leresche N, Cope DW.

In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.

5.

Augmentation of Tonic GABA(A) Inhibition in Absence Epilepsy: Therapeutic Value of Inverse Agonists at Extrasynaptic GABA(A) Receptors.

Errington AC, Cope DW, Crunelli V.

Adv Pharmacol Sci. 2011;2011:790590. doi: 10.1155/2011/790590. Epub 2011 Sep 5.

6.

Transition to absence seizures and the role of GABA(A) receptors.

Crunelli V, Cope DW, Terry JR.

Epilepsy Res. 2011 Dec;97(3):283-9. doi: 10.1016/j.eplepsyres.2011.07.011. Epub 2011 Sep 1. Review.

7.

mGluR control of interneuron output regulates feedforward tonic GABAA inhibition in the visual thalamus.

Errington AC, Di Giovanni G, Crunelli V, Cope DW.

J Neurosci. 2011 Jun 8;31(23):8669-80. doi: 10.1523/JNEUROSCI.0317-11.2011.

8.

Aberrant GABA(A) receptor-mediated inhibition in cortico-thalamic networks of succinic semialdehyde dehydrogenase deficient mice.

Errington AC, Gibson KM, Crunelli V, Cope DW.

PLoS One. 2011 Apr 19;6(4):e19021. doi: 10.1371/journal.pone.0019021.

9.

Non-neuronal, slow GABA signalling in the ventrobasal thalamus targets δ-subunit-containing GABA(A) receptors.

Jiménez-González C, Pirttimaki T, Cope DW, Parri HR.

Eur J Neurosci. 2011 Apr;33(8):1471-82. doi: 10.1111/j.1460-9568.2011.07645.x. Epub 2011 Mar 13.

10.

Enhanced tonic GABAA inhibition in typical absence epilepsy.

Cope DW, Di Giovanni G, Fyson SJ, Orbán G, Errington AC, Lorincz ML, Gould TM, Carter DA, Crunelli V.

Nat Med. 2009 Dec;15(12):1392-8. doi: 10.1038/nm.2058. Epub 2009 Nov 22.

11.

Extrasynaptic GABAA receptors: form, pharmacology, and function.

Belelli D, Harrison NL, Maguire J, Macdonald RL, Walker MC, Cope DW.

J Neurosci. 2009 Oct 14;29(41):12757-63. doi: 10.1523/JNEUROSCI.3340-09.2009. Review.

12.

Novel modes of rhythmic burst firing at cognitively-relevant frequencies in thalamocortical neurons.

Hughes SW, Errington A, Lorincz ML, Kékesi KA, Juhász G, Orbán G, Cope DW, Crunelli V.

Brain Res. 2008 Oct 15;1235:12-20. doi: 10.1016/j.brainres.2008.06.029. Epub 2008 Jun 19. Review.

13.

NeuReal: an interactive simulation system for implementing artificial dendrites and large hybrid networks.

Hughes SW, Lorincz M, Cope DW, Crunelli V.

J Neurosci Methods. 2008 Apr 30;169(2):290-301. Epub 2007 Nov 1.

14.

Nucleus- and species-specific properties of the slow (<1 Hz) sleep oscillation in thalamocortical neurons.

Zhu L, Blethyn KL, Cope DW, Tsomaia V, Crunelli V, Hughes SW.

Neuroscience. 2006 Aug 25;141(2):621-636. doi: 10.1016/j.neuroscience.2006.04.069. Epub 2006 Jun 13.

15.

Thalamic T-type Ca2+ channels and NREM sleep.

Crunelli V, Cope DW, Hughes SW.

Cell Calcium. 2006 Aug;40(2):175-90. Epub 2006 Jun 13. Review.

16.

Neuronal basis of the slow (<1 Hz) oscillation in neurons of the nucleus reticularis thalami in vitro.

Blethyn KL, Hughes SW, Tóth TI, Cope DW, Crunelli V.

J Neurosci. 2006 Mar 1;26(9):2474-86.

17.

GABAA receptor-mediated tonic inhibition in thalamic neurons.

Cope DW, Hughes SW, Crunelli V.

J Neurosci. 2005 Dec 14;25(50):11553-63.

18.

What to wear today? Effect of doctor's attire on the trust and confidence of patients.

Rehman SU, Nietert PJ, Cope DW, Kilpatrick AO.

Am J Med. 2005 Nov;118(11):1279-86.

PMID:
16271913
19.

Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation.

Cope DW, Halbsguth C, Karayannis T, Wulff P, Ferraguti F, Hoeger H, Leppä E, Linden AM, Oberto A, Ogris W, Korpi ER, Sieghart W, Somogyi P, Wisden W, Capogna M.

Eur J Neurosci. 2005 Jun;21(11):3002-16.

PMID:
15978011
20.

Thyroid disorders in elderly patients.

Rehman SU, Cope DW, Senseney AD, Brzezinski W.

South Med J. 2005 May;98(5):543-9. Review.

PMID:
15954511
21.

The 'window' T-type calcium current in brain dynamics of different behavioural states.

Crunelli V, Tóth TI, Cope DW, Blethyn K, Hughes SW.

J Physiol. 2005 Jan 1;562(Pt 1):121-9. Epub 2004 Oct 21. Review.

22.

Abolition of zolpidem sensitivity in mice with a point mutation in the GABAA receptor gamma2 subunit.

Cope DW, Wulff P, Oberto A, Aller MI, Capogna M, Ferraguti F, Halbsguth C, Hoeger H, Jolin HE, Jones A, McKenzie AN, Ogris W, Poeltl A, Sinkkonen ST, Vekovischeva OY, Korpi ER, Sieghart W, Sigel E, Somogyi P, Wisden W.

Neuropharmacology. 2004 Jul;47(1):17-34.

PMID:
15165831
23.

Synchronized oscillations at alpha and theta frequencies in the lateral geniculate nucleus.

Hughes SW, Lörincz M, Cope DW, Blethyn KL, Kékesi KA, Parri HR, Juhász G, Crunelli V.

Neuron. 2004 Apr 22;42(2):253-68.

24.
25.

Evaluating group visits in an uninsured or inadequately insured patient population with uncontrolled type 2 diabetes.

Clancy DE, Cope DW, Magruder KM, Huang P, Salter KH, Fields AW.

Diabetes Educ. 2003 Mar-Apr;29(2):292-302.

PMID:
12728756
26.

Novel neuronal and astrocytic mechanisms in thalamocortical loop dynamics.

Crunelli V, Blethyn KL, Cope DW, Hughes SW, Parri HR, Turner JP, Tòth TI, Williams SR.

Philos Trans R Soc Lond B Biol Sci. 2002 Dec 29;357(1428):1675-93. Review.

27.

Metastatic gastroesophageal adenocarcinoma to skeletal muscle: a unique event.

Rehman SU, Cope DW, Basile JN.

South Med J. 2002 Sep;95(9):1076-8.

PMID:
12356116
28.

Properties and origin of spikelets in thalamocortical neurones in vitro.

Hughes SW, Blethyn KL, Cope DW, Crunelli V.

Neuroscience. 2002;110(3):395-401.

PMID:
11906781
29.

Cellular mechanisms of the slow (<1 Hz) oscillation in thalamocortical neurons in vitro.

Hughes SW, Cope DW, Blethyn KL, Crunelli V.

Neuron. 2002 Mar 14;33(6):947-58.

30.
31.

Somatostatin inhibits GABAergic transmission in the sensory thalamus via presynaptic receptors.

Leresche N, Asprodini E, Emri Z, Cope DW, Crunelli V.

Neuroscience. 2000;98(3):513-22.

PMID:
10869845
32.
33.

Behavioral medicine teaching rounds: improving doctor-patient interaction skills.

Harvey RT, Cope DW.

Acad Med. 2000 May;75(5):561-2. No abstract available.

PMID:
10824848
34.

All thalamocortical neurones possess a T-type Ca2+ 'window' current that enables the expression of bistability-mediated activities.

Hughes SW, Cope DW, Tóth TI, Williams SR, Crunelli V.

J Physiol. 1999 Jun 15;517 ( Pt 3):805-15.

35.
36.

Restructuring VA ambulatory care and medical education: the PACE model of primary care.

Cope DW, Sherman S, Robbins AS.

Acad Med. 1996 Jul;71(7):761-71.

PMID:
9158344
37.

Improving patient quality of life with feedback to physicians about functional status.

Rubenstein LV, McCoy JM, Cope DW, Barrett PA, Hirsch SH, Messer KS, Young RT.

J Gen Intern Med. 1995 Nov;10(11):607-14.

PMID:
8583263
38.

Expert ratings of primary care goals and objectives.

Robbins AS, Cope DW, Campbell L, Vivell S.

J Gen Intern Med. 1995 Aug;10(8):429-35.

PMID:
7472699
39.

Internal medicine patients' expectations for care during office visits.

Kravitz RL, Cope DW, Bhrany V, Leake B.

J Gen Intern Med. 1994 Feb;9(2):75-81.

PMID:
8164081
40.
41.

Measuring physicians' humanistic attitudes, values, and behaviors.

Linn LS, DiMatteo MR, Cope DW, Robbins A.

Med Care. 1987 Jun;25(6):504-15.

PMID:
3695659
42.

Modification of residents' behavior by preceptor feedback of patient satisfaction.

Cope DW, Linn LS, Leake BD, Barrett PA.

J Gen Intern Med. 1986 Nov-Dec;1(6):394-8.

PMID:
3794839
43.

Use of nonphysician staff to evaluate humanistic behavior of internal medicine residents and faculty members.

Linn LS, Oye RK, Cope DW, DiMatteo MR.

J Med Educ. 1986 Nov;61(11):918-20. No abstract available.

PMID:
3772969
44.

Factors associated with life satisfaction among practicing internists.

Linn LS, Yager J, Cope DW, Leake B.

Med Care. 1986 Sep;24(9):830-7.

PMID:
3762246
45.

Affect and neutrality in physician behavior: a study of patients' values and satisfaction.

DiMatteo MR, Linn LS, Chang BL, Cope DW.

J Behav Med. 1985 Dec;8(4):397-409.

PMID:
4093975
46.

The effect of gender and training of residents on satisfaction ratings by patients.

Linn LS, Cope DW, Leake B.

J Med Educ. 1984 Dec;59(12):964-6. No abstract available.

PMID:
6502667
47.

Consumer values and subsequent satisfaction ratings of physician behavior.

Linn LS, DiMatteo MR, Chang BL, Cope DW.

Med Care. 1984 Sep;22(9):804-12.

PMID:
6492909
48.

A behavioral medicine course for postgraduate trainees in internal medicine.

Linn LS, Young RT, Heinrich RM, Lewis MA, Yager J, Cope DW.

J Med Educ. 1980 Feb;55(2):133-5. No abstract available.

PMID:
7354483

Supplemental Content

Support Center